The Role of Justicia Adhatoda as Prophylaxis for COVID-19 – Analysis Based on Docking Study

(E-pub Ahead of Print)

Author(s): Pugazhenthan Thangaraju*, Sree Sudha TY, Praveen Kumar Pasala, Sri Hari TY, Sajitha Venkatesan, Eswaran Thangaraju

Journal Name: Infectious Disorders - Drug Targets
Formerly Current Drug Targets - Infectious Disorders

Article ID: e160921190441
Become EABM
Become Reviewer
Call for Editor


Coronavirus cause severe harm to the health of both humans as well as animals, creating a major global health problem affecting millions of populations. Considering situational emergency of identifying novel targeted therapy, we have chosen herbal compound Adathoda justice/ vasica which is high potent olden vital compound having key role in various respiratory conditions with multiple beneficial uses. Adathoda is promoted and supported by the Ministry of AYUSH for symptomatic management of respiratory ailments in case of COVID 19. In this study, we focused Adathoda primary active alkaloid vasicine efficacy against coronavirus infectious symptoms, evaluated by in Silico screening studies on virus proteins ACE 2 Receptor, 3CL protease and Spike protein SARS HR1 motif using PyRx tool and AutoDoc 1.5.6. Based on PyRx results, Vasicine with ACE 2 Receptor shown higher docking affinity score -7.1 K/cal respectively when compared to other virus proteins. AutoDoc 1.5.6 screening study report showed that vasicine promotes good inhibitory constant 486.54 mM on 3CL protease more than others. Results reveal that the vasicine could be a potential target for the treatment of COVID 19. This study adds strong evidence to the claim by the advisory released by AYUSH. Based on the results with available literature Adathoda could be a drug helpful in relieving symptoms in non COVID cases those who were quarantined or in lockdown pace thereby reducing pandemic panic and in confirmed asymptomatic or mild cases. For usage in moderate to severe cases this could be an add on therapy with existing modern medical therapy.

Keywords: Coronavirus infections, Adathoda vasica, vasicine, In silico, PyRx, AutoDoc vina, Virus proteins.

Rights & PermissionsPrintExport Cite as

Article Details

Article ID: e160921190441
Published on: 19 January, 2021
(E-pub Ahead of Print)
DOI: 10.2174/1871526521666210119120643
Price: $95

Article Metrics

PDF: 256